Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17512003 | 0.84 | ALDH1A1 (0.40) | — | |
| SCHEMBL3115380 | 0.81 | ALDH1A1 (0.38) | — | |
| SCHEMBL31156802 | 0.76 | HTR2C (0.34) | HTR2C | |
| SCHEMBL545230 | 0.76 | TSHR (0.44) | — | |
| SCHEMBL59695 | 0.76 | TSHR (0.42) | — | |
| SCHEMBL16534227 | 0.75 | NAAA (0.44) | — | |
| SCHEMBL11049650 | 0.75 | TSHR (0.41) | — | |
| SCHEMBL1679630 | 0.75 | ATM (0.34) | — | |
| SCHEMBL18916913 | 0.74 | — | — | |
| SCHEMBL28425210 | 0.73 | ATM (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2788436-B1 | TREATMENT OF FILLER WITH SILANE | DOW CORNING (US) | 2016-10-12 | — | — | EP | disclosed |
| US-9080057-B2 | Treatment of filler with silane | DOW CORNING CORPORATION (US) | 2015-07-14 | — | — | US | disclosed |
| US-20140350152-A1 | Treatment Of Filler With Silane | DOW SILICONES CORPORATION | 2014-11-27 | — | — | US | disclosed |
| US-20140329976-A1 | Treatment Of Filler With Silane | DOW CORNING EUROPE S.A. (BE) | 2014-11-06 | — | — | US | disclosed |
| EP-2788435-A1 | TREATMENT OF FILLER WITH SILANE | Dow Corning Corporation (US) | 2014-10-15 | — | — | EP | disclosed |
| EP-2788436-A1 | TREATMENT OF FILLER WITH SILANE | Dow Corning Corporation (US) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013083748-A1 | TREATMENT OF FILLER WITH SILANE | DOW CORNING CORPORATION (US) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013083746-A1 | TREATMENT OF FILLER WITH SILANE | DOW CORNING CORPORATION (US) | 2013-06-13 | — | — | WO | disclosed |
| US-20100271699-A1 | COATING COMPOSITION FOR ANTIREFLECTION AND ANTIREFLECTION FILM PREPARED BY USING THE SAME | LG CHEM, LTD. (KR) | 2010-10-28 | — | — | US | disclosed |
| US-20100265580-A1 | COATING COMPOSITION FOR ANTIREFLECTION, ANTIREFLECTION FILM AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140329976-A1 | Treatment Of Filler With Silane | CD44, ASAH2, COL2A1 | HTR2C 1060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.